Posts Tagged ‘biotech’

There’s been a lot of talk recently about SharePoint 2016. This latest version is especially appealing to life sciences companies because it supports the flexibility of a hybrid on-site/cloud implementation. That means that organizations who aren’t quite ready to fully embrace the cloud have the power to host certain features in-house behind their firewall and […]

Over the past several weeks, I’ve published a series of posts that focus on segments of an article published by McKinsey & Company called “How pharma can win in a digital world.” (See the bottom of this post for links to the previous posts.) At the end of the McKinsey article, the authors describe “three […]

I came across an article that celebrated Genentech’s 40 years in business with a few fun facts and stories about the biotechnology pioneer: Founded on April 7, 1976 The name Genentech stems from GENetic ENgineering TECHnology The company was founded with a $1,000 investment in 1976 by Robert Swanson, a venture capitalist, and Herbert Boyer, […]

A couple of weeks ago, I took an in-depth look at the second of three critical themes for success in the digital age, as identified by McKinsey & Company through interviews with 20 pharma executives: It is time to reimagine them as solutions companies, not asset companies. In today’s post, I’d like to take a […]

The other day, I was on a business development call in which the Appian platform was discussed. Appian happens to be a “Leader” in Gartner’s 2015 Magic Quadrant for Intelligent Business Process Management Suites. Not too shabby. The presenter talked about Perficient’s successes with Appian in financial services and healthcare, but when I heard him […]

The deployment of business process management (BPM) strategies in a digital world revolves heavily around leveraging software platforms to automate pieces of or even complete processes. Whether you’re in clinical operations, safety and pharmacovigilance, or a back-office department, BPM technology solutions can be used to address virtually any business challenge that involves a process. Join […]

In a recent post, I took an in-depth look at the first of three critical themes for success in the digital age, as identified by McKinsey & Company through interviews with 20 pharma executives: 

Now that May is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in April – they’re ranked in order of popularity, with number one being the most viewed piece. From Laptops To Tablets: Eli Lilly Bought […]

In a recent blog post, I mentioned the three critical themes for success in the digital age, as identified by McKinsey & Company through interviews with 20 pharma executives: 

I don’t often see FDA Warning Letters issued to Institutional Review Boards (IRBs), so, when I came across this one, I thought it was worth sharing with you. This particular IRB was found to be in violation of 21 CFR Part 56.115(a)(2), related to meeting minutes, and 21 CFR Part 56.115(a)(5), related to a complete […]

If you’re an avid reader of this blog, you’ve probably seen several posts highlighting Quintiles, the world’s largest contract research organization (CRO). That’s for good reason. Not only is the global CRO at the top of its game, when it comes to running all aspects of clinical trials for their clients, they’re leading the way […]

Last week, I wrote a post about an article published by McKinsey & Company in which they interviewed 20 pharma executives about how they’re handling digital transformation. The article was jam-packed with great information, so I wanted to highlight a few more points for you.